RHI Stock Analysis: Robert Half International | NYSE
Staffing & Employment Services | NYSE, USA | Market Cap: 3.410m USD | 12M Return: 21.4% | US7703231032 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 58.3M
EPS Trend: -99.7%
Qual. Beats: 0
Rev. Trend: -98.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Robert Half Inc. (NYSE: RHI) is a global provider of talent solutions and business consulting services, operating through three segments: Contract Talent Solutions, Permanent Placement Talent Solutions, and Protiviti. The Contract Talent segment supplies temporary professionals across finance, accounting, technology, marketing, legal, administrative, and customer support fields, while the Permanent Placement segment focuses on full-time accounting, finance, and tax operations roles. The Protiviti segment delivers consulting and managed solutions in areas such as regulatory compliance, internal audit, risk, technology, and digital.
The company markets its services through radio, digital advertising, job boards, alliance partners, and events, operating under the Robert Half and Protiviti brands. Founded in 1948 and headquartered in Menlo Park, California, the firm was renamed from Robert Half International Inc. to Robert Half Inc. in July 2023. As a mid-cap stock in the Human Resource & Employment Services sub-industry, Robert Halfs revenue tends to track broader labor market trends, with demand for contract and temporary staffing often rising during periods of business uncertainty or hiring freezes, while permanent placement activity typically expands during periods of economic growth.
- Contract staffing bill rates compress as US hiring slows
- Protiviti consulting revenue accelerates on regulatory and tech demand
- Permanent placement fees decline amid recession concerns
| Net Income: 114.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.53 > 1.0 |
| NWC/Revenue: 12.88% < 20% (prev 13.56%; Δ -0.68% < -1%) |
| CFO/TA 0.09 > 3% & CFO 256.3m > Net Income 114.8m |
| Net Debt (-83.9m) to EBITDA (155.7m): -0.54 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.3m) vs 12m ago -0.47% < -2% |
| Gross Margin: 36.80% > 18% (prev 37.62%; Δ -0.82% > 0.5%) |
| Asset Turnover: 186.0% > 50% (prev 196.6%; Δ -10.60% > 0%) |
| Interest Coverage Ratio: 0.75 > 6 (EBIT TTM 79.8m / Interest Expense TTM 106.1m) |
| A: 0.24 (Total Current Assets 2.14b - Total Current Liabilities 1.46b) / Total Assets 2.86b |
| B: 0.0 (Retained Earnings 0.0 / Total Assets 2.86b) |
| C: 0.03 (EBIT TTM 79.8m / Avg Total Assets 2.85b) |
| D: 0.73 (Book Value of Equity 1.21b / Total Liabilities 1.65b) |
| Altman-Z'' = 2.52 = A |
| DSRI: 1.05 (Receivables 821.4m/826.9m, Revenue 5.29b/5.57b) |
| GMI: 1.02 (GM 37.62% / 36.80%) |
| AQI: 0.93 (AQ_t 0.14 / AQ_t-1 0.15) |
| SGI: 0.95 (Revenue 5.29b / 5.57b) |
| TATA: -0.05 (NI 114.8m - CFO 256.3m) / TA 2.86b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of October 22, 2026, the stock is trading at USD 34.64 with a total of 1,049,143 shares traded. Over the past week, the price has changed by -0.97%, over one month by -6.28%, over three months by -14.73% and over the past year by +21.40%.
Current recommended Stop Loss: 31.20 (which is 9.9% or 2.3 ATR below the current price).
Robert Half International has received a consensus analysts rating of 3.09. Therefore, it is recommended to hold RHI.
- StrongBuy: 4
- Buy: 0
- Hold: 3
- Sell: 1
- StrongSell: 3
| Analysts Target Price | 35 | 1% |
P/E Trailing = 28.9652
P/E Forward = 16.6945
P/S = 0.6441
P/B = 3.1853
P/EG = 5.4559
Revenue TTM = 5.29b USD
EBIT TTM = 79.8m USD
EBITDA TTM = 155.7m USD
Long Term Debt = 174.3m USD (estimated: total debt 240.8m - short term 66.5m)
Short Term Debt = 66.5m USD (from shortTermDebt, last quarter)
Debt = 240.8m USD (from shortLongTermDebtTotal, last quarter) (leases 240.8m already included)
Net Debt = -83.9m USD (calculated: Debt 240.8m - CCE 324.7m)
Enterprise Value = 3.33b USD (3.41b + Debt 240.8m - CCE 324.7m)
Interest Coverage Ratio = 0.75 (Ebit TTM 79.8m / Interest Expense TTM 106.1m)
EV/FCF = 15.46x (Enterprise Value 3.33b / FCF TTM 215.1m)
FCF Yield = 6.47% (FCF TTM 215.1m / Enterprise Value 3.33b)
FCF Margin = 4.06% (FCF TTM 215.1m / Revenue TTM 5.29b)
Net Margin = 2.17% (Net Income TTM 114.8m / Revenue TTM 5.29b)
Gross Margin = 36.80% ((Revenue TTM 5.29b - Cost of Revenue TTM 3.35b) / Revenue TTM)
Gross Margin QoQ = 35.47% (prev 36.91%)
Tobins Q-Ratio = 1.16 (Enterprise Value 3.33b / Total Assets 2.86b)
Interest Expense / Debt = 44.06% (Interest Expense 106.1m / Debt 240.8m)
Taxrate = 37.17% (67.9m / 182.7m)
NOPAT = 50.1m (EBIT 79.8m * (1 - 37.17%))
Current Ratio = 1.47 (Total Current Assets 2.14b / Total Current Liabilities 1.46b)
Debt / Equity = 0.20 (Debt 240.8m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = -0.54 (Net Debt -83.9m / EBITDA 155.7m)
Debt / FCF = -0.39 (Net Debt -83.9m / FCF TTM 215.1m)
Total Stockholder Equity = 1.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.03% (Net Income 114.8m / Total Assets 2.86b)
RoE = 9.18% (Net Income TTM 114.8m / Total Stockholder Equity 1.25b)
RoCE = 5.60% (EBIT 79.8m / Capital Employed (Equity 1.25b + L.T.Debt 174.3m))
RoIC = 4.16% (NOPAT 50.1m / Invested Capital 1.20b)
WACC = 9.18% (E(3.41b)/V(3.65b) * Re(7.87%) + D(240.8m)/V(3.65b) * Rd(44.06%) * (1-Tc(0.37)))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.53 | Cagr: -1.76%
[DCF] Terminal Value 70.06% ; FCFF base≈242.9m ; Y1≈213.0m ; Y5≈172.1m
[DCF] Fair Price = 24.57 (EV 2.43b - Net Debt -83.9m = Equity 2.52b / Shares 102.4m; r=9.18% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -99.67 | EPS CAGR: -39.50% | SUE: 0.0 | # QB: 0
Revenue Correlation: -98.13 | Revenue CAGR: -7.71% | SUE: 0.56 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.47 | Chg30d=+0.00% | Revisions=+38% | Analysts=8
EPS current Year (2026-12-31): EPS=1.26 | Chg30d=-0.72% | Revisions=-25% | GrowthEPS=-4.9% | GrowthRev=-1.3%
EPS next Year (2027-12-31): EPS=1.97 | Chg30d=-0.02% | Revisions=-25% | GrowthEPS=+56.1% | GrowthRev=+4.1%
[Analyst] Revisions Ratio: +10% (up=4, down=3)